Castle Biosciences, Inc. Share Price
Stocks
CSTL
US14843C1053
Medical Equipment, Supplies & Distribution
|
Real-time Estimate
Cboe BZX
08:58:16 27/08/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 34.62 USD | +1.57% |
|
+4.56% | -11.49% |
| 17/08 | Castle Biosciences Gets Approval for Dual Listing on Nasdaq Texas | MT |
| 31/07 | Castle Biosciences, Inc., Q2 2026 Earnings Call, Jul 30, 2026 |
| Market Cap | 104.11Cr 89Cr 84Cr 77Cr 144.57Cr 9.93TCr 145.27Cr 992.58Cr 384.67Cr 5.01TCr 390.91Cr 382.43Cr 17TCr | P/E 2026 * |
-26.8x | P/E 2027 * | -34.5x |
|---|---|---|---|---|---|
| Enterprise Value | 104.11Cr 89Cr 84Cr 77Cr 144.57Cr 9.93TCr 145.27Cr 992.58Cr 384.67Cr 5.01TCr 390.91Cr 382.43Cr 17TCr | EV / Sales 2026 * |
2.79x | EV / Sales 2027 * | 2.54x |
| Free-Float |
97.53% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript : Castle Biosciences, Inc.
| 1 day | +1.01% | ||
| 1 week | +4.56% | ||
| Current month | +22.96% | ||
| 1 month | +40.88% | ||
| 3 months | +61.95% | ||
| 6 months | +16.44% | ||
| Current year | -11.49% |
| 1 week | 31.7 |  | 35.2 |
| 1 month | 23.73 | | 35.2 |
| Current year | 17.72 | | 44.28 |
| 1 year | 17.72 | | 44.28 |
| 3 years | 12.07 | | 44.28 |
| 5 years | 9.26 | | 78.58 |
| 10 years | 9.26 | | 107.69 |
| Manager | Title | Age | Since |
|---|---|---|---|
Derek Maetzold
CEO | Chief Executive Officer | 64 | 01/09/2007 |
Franklin Stokes
DFI | Director of Finance/CFO | 56 | 01/12/2017 |
Johnson Clare
CTO | Chief Tech/Sci/R&D Officer | - | 01/07/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Derek Maetzold
BRD | Director/Board Member | 64 | 01/09/2007 |
Daniel Bradbury
CHM | Chairman | 64 | 01/09/2014 |
G. Cole
BRD | Director/Board Member | 70 | 06/12/2018 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 25/08/26 | Sell | Chief Operating Officer | -12,384 | 0.0408% | ||
| 17/08/26 | Sell | Executive/Senior Manager | -1,730 | 0.0057% | ||
| 14/08/26 | Sell | Chief Financial Officer | -24,908 | 0.0821% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.57% | +4.56% | +54.53% | +83.33% | 104.11Cr | |
| -0.12% | +1.15% | +167.42% | +344.30% | 2.29TCr | |
| +1.21% | +0.74% | -36.85% | -21.85% | 1.02TCr | |
| +0.23% | +0.63% | +358.45% | +36.06% | 837.25Cr | |
| +1.77% | +9.93% | -29.30% | - | 757.92Cr | |
| +0.15% | +0.69% | +77.58% | +52.01% | 658.08Cr | |
| -0.12% | -3.82% | -14.67% | -10.78% | 602.42Cr | |
| +1.61% | +3.00% | -9.65% | -18.77% | 436.34Cr | |
| -2.48% | -11.72% | +56.86% | +98.49% | 418.78Cr | |
| +0.26% | -0.55% | -19.52% | -24.57% | 283.95Cr | |
| Average | +0.36% | +2.56% | +60.48% | +59.80% | 741.13Cr | |
| Weighted average by Cap. | +0.32% | +3.43% | +92.60% | +129.28% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 37Cr 32Cr 30Cr 27Cr 52Cr 3.56TCr 52Cr 355.51Cr 137.78Cr 1.79TCr 140.01Cr 136.97Cr 5.94TCr | 41Cr 35Cr 33Cr 30Cr 57Cr 3.91TCr 57Cr 390.34Cr 151.27Cr 1.97TCr 153.73Cr 150.39Cr 6.53TCr |
| Net income | -3.8Cr -3.26Cr -3.06Cr -2.8Cr -5.28Cr -362.76Cr -5.31Cr -36Cr -14Cr -183.01Cr -14Cr -14Cr -606.15Cr | -2.78Cr -2.38Cr -2.24Cr -2.04Cr -3.85Cr -264.69Cr -3.87Cr -26Cr -10Cr -133.53Cr -10Cr -10Cr -442.28Cr |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 27/26/27 | $34.43 | +1.03% | 34,292 |
| 26/26/26 | $34.08 | -2.63% | 4,56,263 |
| 25/26/25 | $35.00 | +4.57% | 4,83,371 |
| 24/26/24 | $33.47 | -2.13% | 3,57,666 |
| 21/26/21 | $34.20 | +3.86% | 5,73,470 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CSTL Stock
Select your edition
All financial news and data tailored to specific country editions
